PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,210 | -85.5% | 15,289 | -80.5% | 0.01% | -86.0% |
| Q2 2023 | $276,929 | +9.8% | 78,450 | -3.9% | 0.05% | -5.7% |
| Q1 2023 | $252,203 | -36.8% | 81,619 | -13.5% | 0.05% | -37.6% |
| Q4 2022 | $399,122 | +504.7% | 94,355 | +236.3% | 0.08% | +431.2% |
| Q3 2022 | $66,000 | -35.9% | 28,056 | -22.3% | 0.02% | -61.9% |
| Q2 2022 | $103,000 | -41.5% | 36,130 | -41.0% | 0.04% | -45.5% |
| Q1 2022 | $176,000 | +91.3% | 61,218 | +102.0% | 0.08% | +48.1% |
| Q4 2021 | $92,000 | -36.1% | 30,308 | +93.0% | 0.05% | +6.1% |
| Q2 2021 | $144,000 | – | 15,705 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |